Fuso Chemical Co.,Ltd.

TSE:4368.T

3750 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 58,970.27368,459.39255,760.48242,209.3841,310.68942,074.72140,221.61936,224.35635,298.62932,223.52529,327.47127,355.26328,247.87830,251.93829,798.41730,077.90330,833.54427,059.87924,463.23921,736.215
Cost of Revenue 38,398.08440,048.35932,679.13325,861.58425,896.34825,944.63122,980.12819,965.49921,331.21720,571.58318,910.33916,946.11517,137.99218,267.13119,467.93521,827.41820,575.12717,899.52716,801.1114,296.33
Gross Profit 20,572.18928,411.03323,081.34916,347.79615,414.34116,130.0917,241.49116,258.85713,967.41211,651.94210,417.13210,409.14811,109.88611,984.80710,330.4828,250.48510,258.4179,160.3527,662.1297,439.885
Gross Profit Ratio 0.3490.4150.4140.3870.3730.3830.4290.4490.3960.3620.3550.3810.3930.3960.3470.2740.3330.3390.3130.342
Reseach & Development Expenses 850.376845688685633614.663572.341563.862513.66837947148900000000
General & Administrative Expenses 7,038.957,2465,9335,3305,0714,650.4864,561.0314,310.9624,408.7024,6425,3945,70400000000
Selling & Marketing Expenses 1,6002,2342,1131,3851,2531,3261,3091,2201,2321,1681,1091,05400000000
SG&A 8,638.959,4808,0466,7156,3245,976.4865,870.0315,530.9625,640.7025,8106,5036,75800000000
Other Expenses 34.42442.7128.18729.99651.161206.81438.86435.20539.23229.34540.05134.45568.14455.56942.38895.57443.98632.77132.95127.357
Operating Expenses 9,489.3269,480.4228,046.5876,715.5836,583.8016,847.0486,704.3446,391.026,688.1046,225.6426,878.0547,186.0057,201.4957,347.3427,575.6617,628.5817,172.2946,037.2535,754.2075,322.519
Operating Income 11,082.86318,930.61115,034.7619,632.2128,830.5399,283.0410,537.1469,867.8357,279.3075,426.2993,539.0773,223.1423,908.394,637.4642,754.82621.9033,086.1223,123.0991,907.922,117.365
Operating Income Ratio 0.1880.2770.270.2280.2140.2210.2620.2720.2060.1680.1210.1180.1380.1530.0920.0210.10.1150.0780.097
Total Other Income Expenses Net 923.3311,1536809945512.53-1,129.784121.209-101.17431.07-66.849-76.811487.319-695.207-521.686-475.612-301.341-509.789269.687-142.075
Income Before Tax 12,006.19420,082.32115,713.9129,729.5638,875.7769,795.579,407.3629,989.0447,178.1335,457.3693,472.2283,146.3314,395.7093,942.2572,233.134146.2912,784.7812,613.312,177.6071,975.29
Income Before Tax Ratio 0.2040.2930.2820.2310.2150.2330.2340.2760.2030.1690.1180.1150.1560.130.0750.0050.090.0970.0890.091
Income Tax Expense 3,662.8945,952.8614,823.5172,921.4831,861.4532,914.0262,814.1963,092.1322,461.0042,004.1291,210.4891,242.3981,883.7571,609.451794.245-61.3631,024.0181,151.857761.508687.391
Net Income 8,343.29914,129.45910,890.3946,808.0797,014.3236,881.2666,592.2876,895.5944,716.1213,452.0582,258.5541,903.6682,508.1892,331.3861,435.086209.6361,760.7631,409.9071,381.611,252.723
Net Income Ratio 0.1410.2060.1950.1610.170.1640.1640.190.1340.1070.0770.070.0890.0770.0480.0070.0570.0520.0560.058
EPS 236.71400.91308.09191.76197.57193.82185.68194.22143.76109.5771.6860.4279.6173.9945.556.6555.8844.7542.4238.33
EPS Diluted 236.71400.91308.09191.76197.57193.82185.68194.22143.76109.5771.6860.4279.6173.9945.556.6555.8844.7542.4238.33
EBITDA 18,243.02722,935.55919,289.75314,682.83113,441.50112,390.16613,110.6111,258.7629,101.0517,691.8395,490.3054,978.3676,003.2136,828.8095,562.1973,263.855,182.5485,134.873,852.0253,431.839
EBITDA Ratio 0.3090.3350.3460.3480.3250.2940.3260.3110.2580.2390.1870.1820.2130.2260.1870.1090.1680.190.1570.158